Safe Orthopaedics announces its revenues for the third quarter of 2020

€943k - Seite 2

  
Cash Position

At the end of the third quarter 2020, Safe Orthopaedics had cash of €575k versus €581k a year earlier. As a reminder, the General Assembly of Shareholders approved on June 7th, 2019, a €12.15M financing line of which 5 monthly installments of €450k each remain to be paid.

Next financial publication

Annual turnover 2020, Monday, January 14^th, 2021 (post market).
  

About Safe Orthopaedics 

Founded in 2010, Safe Orthopaedics is a French medical technology company, a pioneer of the design and marketing of innovative ready-to-use technologies (single-use implants and instruments) for spinal fractures treatments. The company develops and manufactures kits combining sterile implants and single-use instruments, available at any time for the surgeon. These technologies enable minimally invasive approach, reducing the risk of cross contamination and infection, in the interest of the patient with a positive impact on hospitalization durations and costs. Protected by 17 patent families, the SteriSpineTM PS are CE marked and FDA approved. Safe Orthopaedics has its headquarters close to Paris (95610 Eragny-sur-Oise – France) has subsidiaries in the UK, Germany, United States and in the Lyon area where the manufacturing company is located. The Group employs around 150 employees.

For more information: www.SafeOrthopaedics.com

Contacts 

Safe Orthopaedics                                                                                                                
François-Henri Reynaud